Cannabis Stocks Jump: What Investors Need to Know

Cannabis stocks have started to recover in recent weeks, showing there might be signs that now is the time to buy major brands.

| More on:
A person holds a small glass jar of marijuana.

Source: Getty Images

Shares of cannabis stocks have been jumping over the last month, leading some investors to wonder whether now is the time to get back into the marijuana market. But there are a few things I would note before heading into the smoke-filled sector.

Market still volatile

The important point here is that the global market is still volatile. I don’t just mean the cannabis market but the market as a whole. There is a lot of uncertainty, and with that comes the uncertainty about the future of riskier stocks such as cannabis stocks.

The TSX today is down by 9.6% year to date. That’s certainly an improvement from the week before, when it was down by about 14% year to date. However, it’s still a yo-yo that will continue to toy with our cash for at least the near term.

Given that, it’s unclear as to how the cannabis market is going to perform in the next year. With a potential for a recession in 2023, these are likely to be the last stocks to come in during a rebound, and the first to go out during a recession. So, it’s important to be particularly careful.

But still…

Yet even with all that, it’s just as important to know what’s been going on with the cannabis stocks in general. The world is shifting towards legalizing marijuana, and that includes the United States, where many states have already legalized the product. When that happens, it’s likely to become the largest market of marijuana consumption in the world.

So, with that in mind, it’s clear why investors may be interested in buying up the stock — especially as congress moves through a few changes that could at least see decriminalization on a federal level in the near future.

But still, this doesn’t mean we’re heading back to the days of 2017. In fact, it’s just the opposite. The companies that were around in 2017 have, in large part, moved to the wayside or at least become penny stocks once more — that is, except for a few key cannabis stocks that I would focus on as an investor.

Canopy Growth and Tilray

If you’re looking to invest in cannabis stocks, it’s go big or go home. This would mean investing in the main cannabis providers of Canopy Growth (TSX:WEED), which is down by 65% and Tilray (TSX:TLRY), which is down by 55% year to date. These two companies hold the title of potentially becoming the largest producers in the world, with the United States a large focus.

There are some differences though. Tilray stock has been focused on growing both in the United States and globally as well. Tilray stock also has a large influx of medical marijuana on its roster. Meanwhile, Canopy stock is different. It’s pretty much divested its German assets as well as its medical marijuana brands. Now, Canopy stock is focusing on recreational use, sure, but also on hemp-based and cannabidiol products for consumption pretty much anywhere in the United States.

And that’s the key here. Both companies are laser focused on the United States growth of the cannabis industry. So, if you’re going to buy either, these are the ones to consider.

Bottom line

The cannabis industry is set to boom in the next decade and beyond. But as with all industries, there’s likely to only be a few companies that come out on top. Frankly, it’s a toss up whether it will be Canopy stock or Tilray stock. But, in my opinion, at this point, you can’t go wrong with either, as long as you’re willing to wait it out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Stethoscope with dollar shaped cord
Cannabis Stocks

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth?

While both stocks are risky, Bausch Health is seeing operational momentum, while Canopy Growth is still struggling with losses.

Read more »

Worker checks cannabis flower in lab farm greenhouse
Cannabis Stocks

Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?

Canopy Growth stock remains a high-risk investment in 2025 due to its weak balance sheet and volatile profit margins.

Read more »

money goes up and down in balance
Dividend Stocks

2 Incredibly Cheap Growth Stocks to Buy Now

These two growth stocks are both unbelievably cheap and have significant long-term potential, making them some of the best to…

Read more »

A cannabis plant grows.
Stocks for Beginners

1 Canadian Cannabis Stock Down 57% to Buy Now for Future Growth

Cannabis stocks might seem so 2018, but this one could eventually make a major comeback.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »